Tyra Biosciences Inc
TYRA
Market Cap$1.16B
Close$
$1.50
85.1% downside
Current Fair Value
85.1% downsideOvervalued by 85.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.16 Billion |
|---|---|
| Enterprise Value | $1.08 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.62 |
| Beta | 1.02 |
| Outstanding Shares | 58,668,712 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.99 |
|---|---|
| PEG | -118.08 |
| Price to Sales | - |
| Price to Book Ratio | 2.01 |
| Enterprise Value to Revenue | 2144.56 |
| Enterprise Value to EBIT | -10.76 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tyra Biosciences Inc
2,021 employees